NCT03970070

Brief Summary

This phase II trial studies how well Perioperative Ostomy Self-Management Telehealth (Periop-OSMT) provides patients and their caregivers information about ostomy and ostomy care. Periop-OSMT may help to understand patient preparedness to do ostomy self-care, confidence in doing ostomy self-care, knowledge of ostomy self-care, quality of life, mood, use of medical services, and financial burden.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Jan 2020

Shorter than P25 for phase_2

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 31, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

January 23, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2021

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

1.3 years

First QC Date

May 1, 2019

Last Update Submit

May 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient and family caregiver (FCG) participation

    Assessed by ratio of eligible participants (patient and FCGs) to those enrolled and those who decline participation, reasons for non-participation, number of scheduled study encounters completed, attrition rate between pre- and post-intervention, reasons for attrition/dropout, level of intervention participation including the total number of sessions, number of sessions completed without break-offs, number of break-offs, length (minutes) of sessions, and the ratio of all participants to those who completed \>= 80% of the study.

    Up to 24 months

Secondary Outcomes (3)

  • Patient reported outcomes

    Up to 6 months post-discharge

  • Support person/FCG reported outcomes

    Up to 6 months post-discharge

  • Acceptability of Perioperative Ostomy Self-Management Telehealth

    Up to 24 months

Study Arms (1)

Health service research (Periop-OSMT)

EXPERIMENTAL

Patients and/or support persons/family caregivers complete Periop-OSMT session in-person or via telephone over 20-40 minutes before surgery and before hospital discharge and group telehealth session over 1.5-2 hours at weeks 1-3, 4, 5, 6, and 7 post discharge

Other: Informational InterventionOther: Quality-of-Life AssessmentOther: Questionnaire AdministrationOther: Survey Administration

Interventions

Complete Perioperative Ostomy Self-Management Telehealth program

Health service research (Periop-OSMT)

Ancillary studies

Also known as: Quality of Life Assessment
Health service research (Periop-OSMT)

Ancillary studies

Health service research (Periop-OSMT)

Ancillary studies

Health service research (Periop-OSMT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PATIENT: Scheduled to undergo a surgical procedure that includes the creation of an intestinal stoma (fecal or urinary).
  • PATIENT: Able to read and understand English.
  • PATIENT: Patients scheduled for temporary ostomy procedures
  • SUPPORT PERSON/FCG: Family member/friend identified by the patient as the primary caregiver before and after surgery.
  • SUPPORT PERSON/FCG: Able to read and understand English.
  • Patients with all stages of disease are eligible for the study.
  • The study is open to anyone regardless of gender or ethnicity. Efforts are made to extend the accrual to a representative population.

You may not qualify if:

  • Subjects, who in the opinion of the principal investigator (PI), may not be able to comply with the requirements of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Banner University Medical Center - Tucson

Tucson, Arizona, 85719, United States

Location

City of Hope Medical Center

Duarte, California, 91010, United States

Location

University of Pennsylvania/Abramson Cancer Center

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Virginia Sun

    City of Hope Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2019

First Posted

May 31, 2019

Study Start

January 23, 2020

Primary Completion

May 12, 2021

Study Completion

May 12, 2021

Last Updated

May 16, 2023

Record last verified: 2023-05

Locations